Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Telomir Pharmaceuticals Inc TELO

Telomir Pharmaceuticals, Inc. is a United States-based company. The Company operates as pre-clinical-stage pharmaceutical company focused on developing TELOMIR-1 small molecule to lengthen the deoxyribonucleic acid’s (DNA) protective telomere caps to affect age reversal. It selectively affects the processes that drive the concentration and accumulation of iron and copper in the serum that... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:TELO)

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1

Accesswire 1 day ago

Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday

Accesswire September 26, 2024

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications

Accesswire September 4, 2024

Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs

Accesswire August 20, 2024

Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman

GlobeNewswire August 12, 2024

Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes

GlobeNewswire July 2, 2024

Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel

GlobeNewswire June 17, 2024

Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1

GlobeNewswire May 30, 2024

Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.

GlobeNewswire April 16, 2024

Opinion & Analysis (NDAQ:TELO)

No current opinion is available.

Bullboard Posts (NDAQ:TELO)

InvestorNewsBreaks - Telomir Pharmaceuticals (NASDAQ: TELO)

JUST IN: $TELO InvestorNewsBreaks - Telomir Pharmaceuticals (NASDAQ: TELO) Unveils Preclinical Success of Telomir-1 in Age-Reversal...
whytestocks - 1 day ago

Telo Genomics Receives Approval from the Intellectual Proper

Breaking News: $TELO Telo Genomics Receives Approval from the Intellectual Property Ontario Program (IPON)Toronto, Ontario--(Newsfile...
whytestocks - 3 days ago

Magic pills to extend life

First trials on dogs have miraculous results. Some information on this company that is starting to get out there watch this https...
Patiencemyson - September 9, 2024